Update on pharmacotherapy guidelines for the treatment of neuropathic pain

Neuropathic pain is a common problem in our society affecting nearly 1.5% of the US population. There currently are five medications approved by the US Food and Drug Administration (FDA) for the treatment of neuropathic pain, which include gabapentin, pregabalin, duloxetine, 5% lidocaine patch, and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current pain and headache reports 2006-06, Vol.10 (3), p.185-190
Hauptverfasser:	Dobecki, Douglas A, Schocket, Sanford M, Wallace, Mark S
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressants Central Nervous System Agents - therapeutic use FDA approval Humans Neuralgia - drug therapy Pain Practice Guidelines as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!